SNTI Senti Biosciences Inc
Company Analysis
Latest News
π’ Senti Biosciences is trading 8.35% up in pre-market after announcing $4.5 million financing
Senti Biosciences is trading 8.35% up now at $0.37 after announcing $4.5 million in financing on September 4, 2026. - The package includes a completed $2.0...
Senti Biosciences Announces $4.5M in Financing via Convertible Notes and Equity Commitment
Senti Biosciences disclosed two financing agreements totaling $4.5 million. The company completed a previously announced $2.0 million sale of Senior Secured...
Senti Bio Taps Another $2 Million in Convertible Debt β But Can Drip-Fed Financing Keep a Penny Stock Alive?
Shares shifted as Senti Biosciences (SNTI) jumped 7.9% to $0.37 after authorizing a $2 million third tranche of senior secured convertible notes β a fresh cash...
π’ Senti Biosciences is trading 7.93% up today after authorizing a $2 million note tranche
Senti Biosciences is trading 7.93% up at $0.37 after disclosing a newly authorized $2 million third tranche of senior secured convertible notes. β’ The...
π’ Senti Biosciences is trading 6% up in after-hours trading after disclosing $2 million third note tranche
Senti Biosciences is trading 6% up at $0.36 in after-hours trading after disclosing a newly authorized $2 million third tranche of senior secured convertible...
Senti Biosciences Receives Nasdaq Non-Compliance Notices; Secures $2M Note Financing
Senti Biosciences disclosed it received two separate non-compliance notices from Nasdaq for failing to meet the minimum bid price and minimum stockholders'...
π’ Senti Biosciences Inc is trading 6.68% up in pre-market
SNTI is trading at $0.36, up 6.68% in pre-market.
π΄ Senti Biosciences is trading 5% down today after broader risk-off trading pressured biotech stocks
Senti Biosciences is trading 5.1% down now at $0.35 after broader risk-off trading pressured biotechnology and growth stocks on September 1, 2026. - The XBI...
π’ Senti Biosciences is trading 9.43% up in pre-market β no clear catalyst identified
Senti Biosciences is trading 9.43% up at $0.41; no clear company-specific announcement was identified for September 1, 2026. - The latest major event was the...
π΄ Senti Biosciences is trading 8.6% down today; catalyst remains unclear
Senti Biosciences is trading 8.6% down at $0.37, with todayβs specific catalyst unclear. - No new company-specific announcement or filing dated August 27,...
π’ Senti Biosciences rises 5.6% β Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
π’ Senti Biosciences is trading 5.74% up in pre-market as Nasdaq Composite gains 0.84%
Senti Biosciences is trading 5.74% up at $0.40 in pre-market after no clear company-specific catalyst was identified for August 25, 2026. - The move follows a...
π΄ Senti Biosciences is trading 7.38% down today in after-hours trading β No clear company-specific catalyst identified
Senti Biosciences is trading 7.38% down at $0.35 after no clear company-specific catalyst was identified for August 24, 2026. - Latest results, released...
π΄ Senti Biosciences is trading 12.45% down today as immediate cause remains uncertain
Senti Biosciences is trading at $0.34, down 12.45%, as the immediate cause of the August 24 decline remains uncertain. - Closed at $0.39 on August 21, 2026;...
π΄ Senti Biosciences is trading 8.65% down today in pre-market β no new catalyst identified
Senti Biosciences is trading 8.65% down at $0.35 after closing at $0.39 on August 21, 2026, with no new company-specific announcement identified to explain the...
π΄ Senti Biosciences is trading 10.53% down today with no company-specific announcement identified
Senti Biosciences is trading 10.53% down at $0.39 after falling from its August 20, 2026 close of $0.44; available coverage attributes the decline to...
π΄ Senti Biosciences is trading 5.44% down today amid sector-driven biotech weakness
Senti Biosciences is trading 5.44% down now at $0.41, amid sector-driven biotech weakness. - It fell 5.83% to $0.44 on August 20. - No new company-specific...
π’ Senti Biosciences is trading 10.09% up in pre-market after a sector-driven biotech recovery
Senti Biosciences is trading 10.09% up at $0.48 in pre-market after recovering from the August 20, 2026 regular-session decline, with the move appearing...
π’ Senti Biosciences is trading 6.65% up in after-hours trading after a sector-driven recovery
Senti Biosciences is trading 6.65% up now at $0.47 after recovering from its 5.83% regular-session decline to $0.44 on August 20, 2026; the move appears...
π΄ Senti Biosciences falls 5.3% β Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...